Brandon Couillard
Stock Analyst at Wells Fargo
(4.29)
# 311
Out of 4,835 analysts
122
Total ratings
55.42%
Success rate
14.54%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Downgrades: Equal-Weight | $22 → $6 | $4.13 | +45.28% | 2 | May 8, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,125 → $1,200 | $1,157.44 | +3.68% | 5 | May 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $105 → $78 | $68.31 | +14.19% | 3 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $580 → $570 | $412.06 | +38.33% | 5 | Apr 24, 2025 | |
| A Agilent Technologies | Maintains: Hold | $135 → $116 | $113.77 | +1.96% | 22 | Apr 21, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $130 → $102 | $93.26 | +9.37% | 2 | Apr 17, 2025 | |
| BRKR Bruker | Maintains: Overweight | $75 → $60 | $37.53 | +59.87% | 3 | Apr 17, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $270 | $248.67 | +8.58% | 9 | Apr 17, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $270 | $244.50 | +10.43% | 9 | Apr 17, 2025 | |
| AVTR Avantor | Maintains: Overweight | $25 → $22 | $13.41 | +64.06% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $415 → $420 | $359.48 | +16.84% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $196.11 | +22.38% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $188.29 | +38.08% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $72.05 | +11.03% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $28 → $24 | $17.54 | +36.83% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $56.42 | +50.66% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $126.50 | +42.29% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.10 | +376.19% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $122.42 | -1.98% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $18.27 | +25.89% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.82 | +1,477.67% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.44 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.47 | +345.34% | 2 | Oct 13, 2017 |
Myriad Genetics
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $4.13
Upside: +45.28%
Mettler-Toledo International
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,157.44
Upside: +3.68%
GeneDx Holdings
May 1, 2025
Maintains: Equal-Weight
Price Target: $105 → $78
Current: $68.31
Upside: +14.19%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Overweight
Price Target: $580 → $570
Current: $412.06
Upside: +38.33%
Agilent Technologies
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $113.77
Upside: +1.96%
Revvity
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $93.26
Upside: +9.37%
Bruker
Apr 17, 2025
Maintains: Overweight
Price Target: $75 → $60
Current: $37.53
Upside: +59.87%
Bio-Rad Laboratories
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $320 → $270
Current: $248.67
Upside: +8.58%
Bio-Rad Laboratories
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $320 → $270
Current: $244.50
Upside: +10.43%
Avantor
Apr 17, 2025
Maintains: Overweight
Price Target: $25 → $22
Current: $13.41
Upside: +64.06%
Feb 13, 2025
Maintains: Overweight
Price Target: $415 → $420
Current: $359.48
Upside: +16.84%
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $196.11
Upside: +22.38%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $188.29
Upside: +38.08%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $72.05
Upside: +11.03%
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $17.54
Upside: +36.83%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $56.42
Upside: +50.66%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $126.50
Upside: +42.29%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.10
Upside: +376.19%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $122.42
Upside: -1.98%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $18.27
Upside: +25.89%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.82
Upside: +1,477.67%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.44
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.47
Upside: +345.34%